Lumexa Imaging director reports option on 22,222 shares

Lumexa Imaging Holdings, Inc. director reports beneficial ownership of a stock option covering 22,222 shares of common stock at an exercise price of $18.5 per share, expiring on 12/10/2035.

Rhea-AI Filing Summary

Lumexa Imaging Holdings, Inc. director reports beneficial ownership of a stock option covering 22,222 shares of common stock at an exercise price of $18.5 per share, expiring on 12/10/2035.

The option vests in five substantially equal annual installments starting from a vesting commencement date of March 1, 2025, and each installment requires the director to continue serving with the company. The option is held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Karlin Bridget E

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy)	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 22,222 contracts (Direct)

Footnotes (1)

1. F1. The shares of the Issuer's common stock subject to the stock option vest annually in five substantially equal installments from the vesting commencement date of March 1, 2025, subject to the Reporting Person's continued service with the Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position was reported for Lumexa Imaging Holdings, Inc. (LMRI)?

A director of Lumexa Imaging Holdings, Inc. reported beneficial ownership of a stock option linked to the company’s common stock.

How many Lumexa Imaging (LMRI) shares are covered by the director's stock option?

The stock option covers 22,222 shares of Lumexa Imaging Holdings, Inc. common stock.

What are the exercise price and expiration date of the LMRI director's stock option?

The director's stock option has an exercise price of $18.5 per share and expires on 12/10/2035.

How does the Lumexa Imaging director's stock option vest?

The option vests annually in five substantially equal installments starting from March 1, 2025, subject to the director’s continued service with the company.

Is the Lumexa Imaging (LMRI) director's stock option held directly or indirectly?

The stock option is reported as held in direct ownership by the director.

What is the relationship of the reporting person to Lumexa Imaging Holdings, Inc.?

The reporting person is identified as a director of Lumexa Imaging Holdings, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 07:53 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Karlin Bridget E

(Last) (First) (Middle)

4200 SIX FORKS ROAD

SUITE 1000

(Street)

RALEIGH NC 27609

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/11/2025

3. Issuer Name and Ticker or Trading Symbol
Lumexa Imaging Holdings, Inc. [ LMRI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	12/10/2035	Common Stock	22,222	$18.5	D

Explanation of Responses:

1. The shares of the Issuer's common stock subject to the stock option vest annually in five substantially equal installments from the vesting commencement date of March 1, 2025, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Julie Szeker, attorney-in-fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.